Evan Loh

Track

Insider profile

Currently holds a position at Paratek Pharmaceuticals Inc

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Executive Officer, Chief Operating Officer, Principal Executive Officer, Director Paratek Pharmaceuticals Inc June 25, 2019 -
President, Chief Operating Officer, Chief Medical Officer, Director Paratek Pharmaceuticals Inc Jan. 1, 2017 - June 25, 2019
Independent Director Alpine Immune Sciences Inc None -
President, Chief Medical Officer, Director Paratek Pharmaceuticals Inc Oct. 30, 2014 - Jan. 1, 2017
Evan Loh's trades of Paratek Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-10 2023-08-09
S Sale
33,352 +30.0%
120.05
US$3,058,880 		33,352 +30.0% 120.05 US$3,058,880
2022-12-22 2022-12-21
PlS Planned sale
45,630 +49.0%
390.83
US$3,981,577 		45,630 +49.0% 390.83 US$3,981,577
2022-12-14 2022-12-13
PlS Planned sale
80,043 -42.8%
305.58
US$1,386,861 		80,043 -42.8% 305.58 US$1,386,861
2022-12-14 2022-12-12
PlS Planned sale
37,831 -3.0%
1.98
US$74,905 		37,831 -3.0% 1.98 US$74,905
2022-11-01 2022-10-28
PlS Planned sale
8,805 -0.7%
3.47
US$30,553 		8,805 -0.7% 3.47 US$30,553
2022-08-10 2022-08-09
PlS Planned sale
44,519 -3.4%
2.66
US$118,421 		44,519 -3.4% 2.66 US$118,421
2021-12-15 2021-12-15
PlS Planned sale
49,259 -5.1%
4.27
US$210,336 		49,259 -5.1% 4.27 US$210,336
2021-12-15 2021-12-14
PlS Planned sale
23,834 -2.4%
4.37
US$104,155 		23,834 -2.4% 4.37 US$104,155
2021-12-15 2021-12-13
PlS Planned sale
13,983 -1.4%
4.42
US$61,805 		13,983 -1.4% 4.42 US$61,805
2021-06-08 2021-06-04
PlS Planned sale
36,654 -3.7%
9.70
US$355,544 		36,654 -3.7% 9.70 US$355,544
2021-03-15 2021-03-15
S Sale
2,000 -20.0%
10.14
US$20,280 		2,000 -20.0% 10.14 US$20,280
2020-12-15 2020-12-14
PlS Planned sale
26,415 -4.2%
6.71
US$177,245 		26,415 -4.2% 6.71 US$177,245
2020-12-15 2020-12-11
PlS Planned sale
18,585 -2.9%
6.95
US$129,166 		18,585 -2.9% 6.95 US$129,166
2020-11-16 2020-11-13
PlS Planned sale
20,928 -3.1%
5.93
US$124,103 		20,928 -3.1% 5.93 US$124,103
2020-05-14 2020-05-12
S Sale
9,595 -1.7%
4.75
US$45,576 		9,595 -1.7% 4.75 US$45,576
2019-10-08 2019-10-08
PlS Planned sale
7,818 -1.8%
3.82
US$29,865 		7,818 -1.8% 3.82 US$29,865
2019-10-07 2019-10-03
PlS Planned sale
16,265 -3.8%
3.98
US$64,735 		16,265 -3.8% 3.98 US$64,735
2018-12-14 2018-12-12
PlS Planned sale
5,525 -1.9%
6.76
US$37,349 		5,525 -1.9% 6.76 US$37,349
2018-10-16 2018-10-15
PlS Planned sale
5,200 -1.8%
8.96
US$46,592 		5,200 -1.8% 8.96 US$46,592
2018-07-05 2018-07-02
PlS Planned sale
12,000 -5.6%
9.97
US$119,640 		12,000 -5.6% 9.97 US$119,640
2018-02-07 2018-02-05
PlS Planned sale
3,040 -2.1%
14.22
US$43,229 		3,040 -2.1% 14.22 US$43,229
2017-07-06 2017-07-05
PlS Planned sale
4,351 -3.9%
23.58
US$102,591 		4,351 -3.9% 23.58 US$102,591